Bupivacaine Liposome Versus Bupivacaine for Ultrasound-Guided Suprascapular Nerve Combined With Axillary Nerve Block in Analgesia After Arthroscopic Shoulder Surgery

Starting soon · Phase 4

Conditions studied: Arthroscopic Shoulder Surgery, Ultrasound Guided Nerve Block, Bupivacaine, Suprascapular Nerve Block, Axillary Nerve Block

In brief

This trial is designed to compare the post-operative analgesic efficacy and safety of liposomal bupivacaine versus plain bupivacaine when both are used for ultrasound-guided combined suprascapular and axillary nerve block in patients undergoing elective arthroscopic shoulder surgery.

Key facts

Study ID

NCT07410182

Run by

Huazhong University of Science and Technology

People needed

60

Starts

2026-03-01

Expected to finish

2026-12-30

Last updated by the study team

2026-02-13

Who can join

Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged 18-60 years
• ASA physical status I-II
• Undergoing unilateral arthroscopic shoulder surgery
• The Operative time between 1and 4 hours

You may not qualify if…

• Anticipated operative time < 1 h or > 4 h
• Severe cardiopulmonary insufficiency
• Hepatic or renal dysfunction
• Coagulopathy
• Diabetic peripheral neuropathy
• History of nerve injury on the operative side
• Skin infection at the block site
• Allergy to amide local anesthetics
• Refusal to participate or any other condition deemed unsuitable.

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.